331 related articles for article (PubMed ID: 24731810)
1. Effect of different adjuvant formulations on the immunogenicity and protective effect of a live Mycoplasma hyopneumoniae vaccine after intramuscular inoculation.
Xiong Q; Wei Y; Xie H; Feng Z; Gan Y; Wang C; Liu M; Bai F; Xie F; Shao G
Vaccine; 2014 Jun; 32(27):3445-51. PubMed ID: 24731810
[TBL] [Abstract][Full Text] [Related]
2. Protective efficacy of a live attenuated Mycoplasma hyopneumoniae vaccine with an ISCOM-matrix adjuvant in pigs.
Xiong Q; Wei Y; Feng Z; Gan Y; Liu Z; Liu M; Bai F; Shao G
Vet J; 2014 Feb; 199(2):268-74. PubMed ID: 24314715
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of recombinant Mycoplasma hyopneumoniae P97/P102 paralogs formulated with selected adjuvants as vaccines against mycoplasmal pneumonia in pigs.
Woolley LK; Fell SA; Gonsalves JR; Raymond BB; Collins D; Kuit TA; Walker MJ; Djordjevic SP; Eamens GJ; Jenkins C
Vaccine; 2014 Jul; 32(34):4333-41. PubMed ID: 24930717
[TBL] [Abstract][Full Text] [Related]
4. Immune responses of a chimaeric protein vaccine containing Mycoplasma hyopneumoniae antigens and LTB against experimental M. hyopneumoniae infection in pigs.
Marchioro SB; Sácristan Rdel P; Michiels A; Haesebrouck F; Conceição FR; Dellagostin OA; Maes D
Vaccine; 2014 Aug; 32(36):4689-94. PubMed ID: 24909331
[TBL] [Abstract][Full Text] [Related]
5. Serum and mucosal antibody responses and protection in pigs vaccinated against Mycoplasma hyopneumoniae with vaccines containing a denatured membrane antigen pool and adjuvant.
Djordjevic SP; Eamens GJ; Romalis LF; Nicholls PJ; Taylor V; Chin J
Aust Vet J; 1997 Jul; 75(7):504-11. PubMed ID: 9258425
[TBL] [Abstract][Full Text] [Related]
6. Systemic and local immune response in pigs intradermally and intramuscularly injected with inactivated Mycoplasma hyopneumoniae vaccines.
Martelli P; Saleri R; Cavalli V; De Angelis E; Ferrari L; Benetti M; Ferrarini G; Merialdi G; Borghetti P
Vet Microbiol; 2014 Jan; 168(2-4):357-64. PubMed ID: 24332702
[TBL] [Abstract][Full Text] [Related]
7. Local and systemic immune responses in pigs intramuscularly injected with an inactivated Mycoplasma hyopneumoniae vaccine.
Marchioro SB; Maes D; Flahou B; Pasmans F; Del Pozo Sacristán R; Vranckx K; Melkebeek V; Cox E; Wuyts N; Haesebrouck F
Vaccine; 2013 Feb; 31(9):1305-11. PubMed ID: 23306368
[TBL] [Abstract][Full Text] [Related]
8. [Immunogenicity of attenuated Salmonella choleraesuis vaccine strain expressing immunogenic genes of Mycoplasma hyopneumoniae in mice].
Ma F; Zou H; He Q
Wei Sheng Wu Xue Bao; 2011 Sep; 51(9):1270-7. PubMed ID: 22126084
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a novel oil-in-water emulsion adjuvant for swine influenza virus and Mycoplasma hyopneumoniae vaccines.
Galliher-Beckley A; Pappan LK; Madera R; Burakova Y; Waters A; Nickles M; Li X; Nietfeld J; Schlup JR; Zhong Q; McVey S; Dritz SS; Shi J
Vaccine; 2015 Jun; 33(25):2903-8. PubMed ID: 25936722
[TBL] [Abstract][Full Text] [Related]
10. Local and systemic immune responses induced by a recombinant chimeric protein containing Mycoplasma hyopneumoniae antigens fused to the B subunit of Escherichia coli heat-labile enterotoxin LTB.
Marchioro SB; Fisch A; Gomes CK; Jorge S; Galli V; Haesebrouck F; Maes D; Dellagostin O; Conceição FR
Vet Microbiol; 2014 Sep; 173(1-2):166-71. PubMed ID: 25091529
[TBL] [Abstract][Full Text] [Related]
11. Oral vaccination against mycoplasmal pneumonia of swine using a live Erysipelothrix rhusiopathiae vaccine strain as a vector.
Ogawa Y; Oishi E; Muneta Y; Sano A; Hikono H; Shibahara T; Yagi Y; Shimoji Y
Vaccine; 2009 Jul; 27(33):4543-50. PubMed ID: 19433128
[TBL] [Abstract][Full Text] [Related]
12. A novel chimeric protein composed of recombinant Mycoplasma hyopneumoniae antigens as a vaccine candidate evaluated in mice.
de Oliveira NR; Jorge S; Gomes CK; Rizzi C; Pacce VD; Collares TF; Monte LG; Dellagostin OA
Vet Microbiol; 2017 Mar; 201():146-153. PubMed ID: 28284602
[TBL] [Abstract][Full Text] [Related]
13. Systems Immunology Characterization of Novel Vaccine Formulations for
Matthijs AMF; Auray G; Jakob V; García-Nicolás O; Braun RO; Keller I; Bruggman R; Devriendt B; Boyen F; Guzman CA; Michiels A; Haesebrouck F; Collin N; Barnier-Quer C; Maes D; Summerfield A
Front Immunol; 2019; 10():1087. PubMed ID: 31178860
[TBL] [Abstract][Full Text] [Related]
14. Potential use of a recombinant replication-defective adenovirus vector carrying the C-terminal portion of the P97 adhesin protein as a vaccine against Mycoplasma hyopneumoniae in swine.
Okamba FR; Arella M; Music N; Jia JJ; Gottschalk M; Gagnon CA
Vaccine; 2010 Jul; 28(30):4802-9. PubMed ID: 20472025
[TBL] [Abstract][Full Text] [Related]
15. Immune responses elicited by Mycoplasma hyopneumoniae recombinant antigens and DNA constructs with potential for use in vaccination against porcine enzootic pneumonia.
Virginio VG; Gonchoroski T; Paes JA; Schuck DC; Zaha A; Ferreira HB
Vaccine; 2014 Oct; 32(44):5832-8. PubMed ID: 25148775
[TBL] [Abstract][Full Text] [Related]
16. Interaction of porcine circovirus type 2 and Mycoplasma hyopneumoniae vaccines on dually infected pigs.
Seo HW; Park SJ; Park C; Chae C
Vaccine; 2014 May; 32(21):2480-6. PubMed ID: 24631087
[TBL] [Abstract][Full Text] [Related]
17. The Mycoplasma hyopneumoniae recombinant heat shock protein P42 induces an immune response in pigs under field conditions.
Jorge S; de Oliveira NR; Marchioro SB; Fisch A; Gomes CK; Hartleben CP; Conceição FR; Dellagostin OA
Comp Immunol Microbiol Infect Dis; 2014 Sep; 37(4):229-36. PubMed ID: 25082621
[TBL] [Abstract][Full Text] [Related]
18. Co-administration of attenuated Mycoplasma hyopneumoniae 168 strain with bacterial DNA enhances the local and systemic immune response after intranasal vaccination in pigs.
Li Y; Li P; Wang X; Yu Q; Yang Q
Vaccine; 2012 Mar; 30(12):2153-8. PubMed ID: 22266290
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro comparisons of spray-drying and solvent- evaporation preparation of microencapsulated Mycoplasma hyopneumoniae for use as an orally administered vaccine for pigs.
Lin JH; Pan MJ; Liao CW; Weng CN
Am J Vet Res; 2002 Aug; 63(8):1118-23. PubMed ID: 12171164
[TBL] [Abstract][Full Text] [Related]
20. Blending of a conventional Mycoplasma hyopneumoniae vaccine with a positive marker: tracking of immunised pigs by peptide-specific antibodies raised to the marker component.
Walders B; Raschke A; Neugebauer M; Geuther E; Bertling W; Reiser C; Buck A; Strich S; Hess J
Res Vet Sci; 2005 Apr; 78(2):135-41. PubMed ID: 15563920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
